<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37236359</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>299</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>The Stathmin-2 membrane-targeting domain is required for axon protection and regulated degradation by DLK signaling.</ArticleTitle><Pagination><StartPage>104861</StartPage><MedlinePgn>104861</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">104861</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbc.2023.104861</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0021-9258(23)01889-6</ELocationID><Abstract><AbstractText>Axon integrity is essential for functional connectivity in the nervous system. The degeneration of stressed or damaged axons is a common and sometimes initiating event in neurodegenerative disorders. Stathmin-2 (Stmn2) is an axon maintenance factor that is depleted in amyotrophic lateral sclerosis, and replenishment of Stmn2 can restore neurite outgrowth in diseased neurons. However, mechanisms responsible for Stmn2-mediated axon maintenance in injured neurons are not known. We used primary sensory neurons to interrogate the role of Stmn2 in the degeneration of severed axons. We discover that membrane association of Stmn2 is critical for its axon-protective activity. Structure-function studies revealed that axonal enrichment of Stmn2 is driven by palmitoylation as well as tubulin interaction. Using live imaging, we discover that another Stmn, Stmn3, comigrates with Stmn2-containing vesicles. We also demonstrate that Stmn3 undergoes regulated degradation through dual leucine zipper kinase (DLK)-c-Jun N-terminal kinase signaling. The Stmn2 membrane-targeting domain is both necessary and sufficient for localization to a specific vesicle population and confers sensitivity to DLK-dependent degradation. Our findings reveal a broader role for DLK in tuning the local abundance of palmitoylated Stmns in axon segments. Moreover, palmitoylation is a critical component of Stmn-mediated axon protection, and defining the Stmn2-containing vesicle population will provide important clues toward mechanisms of axon maintenance.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thornburg-Suresh</LastName><ForeName>Emma J C</ForeName><Initials>EJC</Initials><AffiliationInfo><Affiliation>Interdisciplinary Graduate Program in Neuroscience, University of Iowa, Iowa City, Iowa, USA; Department of Biology, University of Iowa, Iowa City, Iowa, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richardson</LastName><ForeName>Jerianne E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Iowa, Iowa City, Iowa, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Summers</LastName><ForeName>Daniel W</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Department of Biology, University of Iowa, Iowa City, Iowa, USA; Iowa Neuroscience Institute, University of Iowa, Iowa City, Iowa, USA. Electronic address: daniel-summers@uiowa.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS126191</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050777">Stathmin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.25</RegistryNumber><NameOfSubstance UI="D020930">MAP Kinase Kinase Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050777" MajorTopicYN="Y">Stathmin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001369" MajorTopicYN="N">Axons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020930" MajorTopicYN="N">MAP Kinase Kinase Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DLK</Keyword><Keyword MajorTopicYN="N">JNK</Keyword><Keyword MajorTopicYN="N">Stmn2</Keyword><Keyword MajorTopicYN="N">Stmn3</Keyword><Keyword MajorTopicYN="N">axon</Keyword><Keyword MajorTopicYN="N">membrane trafficking</Keyword><Keyword MajorTopicYN="N">microtubule</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">palmitoylation</Keyword><Keyword MajorTopicYN="N">protein degradation</Keyword></KeywordList><CoiStatement>Conflict of interest The authors declare they have no conflicts of interest with the contents of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>27</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>26</Day><Hour>19</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37236359</ArticleId><ArticleId IdType="pmc">PMC10404615</ArticleId><ArticleId IdType="doi">10.1016/j.jbc.2023.104861</ArticleId><ArticleId IdType="pii">S0021-9258(23)01889-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gilley J., Orsomando G., Nascimento-Ferreira I., Coleman M.P. Absence of SARM1 rescues development and survival of NMNAT2-deficient axons. Cell Rep. 2015;10:1974&#x2013;1981.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4386025</ArticleId><ArticleId IdType="pubmed">25818290</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilley J., Coleman M.P. Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons. PLoS Biol. 2010;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2811159</ArticleId><ArticleId IdType="pubmed">20126265</ArticleId></ArticleIdList></Reference><Reference><Citation>Figley M.D., Gu W., Nanson J.D., Shi Y., Sasaki Y., Cunnea K., et al. SARM1 is a metabolic sensor activated by an increased NMN/NAD(+) ratio to trigger axon degeneration. Neuron. 2021;109:1118&#x2013;1136.e1111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8174188</ArticleId><ArticleId IdType="pubmed">33657413</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman M.P., Hoke A. Programmed axon degeneration: from mouse to mechanism to medicine. Nat. Rev. Neurosci. 2020;21:183&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8926152</ArticleId><ArticleId IdType="pubmed">32152523</ArticleId></ArticleIdList></Reference><Reference><Citation>Klim J.R., Williams L.A., Limone F., Guerra San Juan I., Davis-Dusenbery B.N., Mordes D.A., et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat. Neurosci. 2019;22:167&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153761</ArticleId><ArticleId IdType="pubmed">30643292</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed Z., Lopez-Erauskin J., Baughn M.W., Zhang O., Drenner K., Sun Y., et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat. Neurosci. 2019;22:180&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>Theunissen F., Anderton R.S., Mastaglia F.L., Flynn L.L., Winter S.J., James I., et al. Novel STMN2 variant linked to amyotrophic lateral sclerosis risk and clinical phenotype. Front. Aging Neurosci. 2021;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8033025</ArticleId><ArticleId IdType="pubmed">33841129</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M., Humphrey J., Pickles S., Brown A.L., Hill S.E., Kachergus J.M., et al. Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. J.&#xa0;Clin. Invest. 2020;130:6080&#x2013;6092.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598060</ArticleId><ArticleId IdType="pubmed">32790644</ArticleId></ArticleIdList></Reference><Reference><Citation>Baughn M.W., Melamed Z., Lopez-Erauskin J., Beccari M.S., Ling K., Zuberi A., et al. Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies. Science. 2023;379:1140&#x2013;1149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10148063</ArticleId><ArticleId IdType="pubmed">36927019</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerra San Juan I., Nash L.A., Smith K.S., Leyton-Jaimes M.F., Qian M., Klim J.R., et al. Loss of mouse Stmn2 function causes motor neuropathy. Neuron. 2022;110:1671&#x2013;1688.e1676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9119928</ArticleId><ArticleId IdType="pubmed">35294901</ArticleId></ArticleIdList></Reference><Reference><Citation>Krus K.L., Strickland A., Yamada Y., Devault L., Schmidt R.E., Bloom A.J., et al. Loss of Stathmin-2, a hallmark of TDP-43-associated ALS, causes motor neuropathy. Cell Rep. 2022;39</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9327139</ArticleId><ArticleId IdType="pubmed">35767949</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Erauskin J., Bravo-Hernandez M., Presa M., Baughn M.W., Melamed Z.e., Beccari M.S., et al. Stathmin-2 loss leads to neurofilament-dependent axonal collapse driving motor and sensory denervation. bioRxiv. 2022 doi: 10.1101/2022.12.11.519794. [preprint]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.12.11.519794</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Zhang Y., Wang M., Song W.-M., Shen Q., McKenzie A., et al. The landscape of multiscale transcriptomic networks and key regulators in Parkinson&#x2019;s disease. Nat. Commun. 2019;10:5234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6868244</ArticleId><ArticleId IdType="pubmed">31748532</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauvin S., Sobel A. Neuronal stathmins: a family of phosphoproteins cooperating for neuronal development, plasticity and regeneration. Prog. Neurobiol. 2015;126:1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">25449700</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori N., Morii H. SCG10-related neuronal growth-associated proteins in neural development, plasticity, degeneration, and aging. J.&#xa0;Neurosci. Res. 2002;70:264&#x2013;273.</Citation><ArticleIdList><ArticleId IdType="pubmed">12391585</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Paolo G., Antonsson B., Kassel D., Riederer B.M., Grenningloh G. Phosphorylation regulates the microtubule-destabilizing activity of stathmin and its interaction with tubulin. FEBS Lett. 1997;416:149&#x2013;152.</Citation><ArticleIdList><ArticleId IdType="pubmed">9369201</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonsson B., Kassel D.B., Di Paolo G., Lutjens R., Riederer B.M., Grenningloh G. Identification of in&#xa0;vitro phosphorylation sites in the growth cone protein SCG10. Effect of phosphorylation site mutants on microtubule-destabilizing activity. J.&#xa0;Biol. Chem. 1998;273:8439&#x2013;8446.</Citation><ArticleIdList><ArticleId IdType="pubmed">9525956</ArticleId></ArticleIdList></Reference><Reference><Citation>Tararuk T., Ostman N., Li W., Bjorkblom B., Padzik A., Zdrojewska J., et al. JNK1 phosphorylation of SCG10 determines microtubule dynamics and axodendritic length. J.&#xa0;Cell Biol. 2006;173:265&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2063817</ArticleId><ArticleId IdType="pubmed">16618812</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin J.E., Miller B.R., Babetto E., Cho Y., Sasaki Y., Qayum S., et al. SCG10 is a JNK target in the axonal degeneration pathway. Proc. Natl. Acad. Sci. U. S. A. 2012;109:E3696&#x2013;E3705.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3535671</ArticleId><ArticleId IdType="pubmed">23188802</ArticleId></ArticleIdList></Reference><Reference><Citation>Summers D.W., Frey E., Walker L.J., Milbrandt J., DiAntonio A. DLK activation Synergizes with mitochondrial dysfunction to downregulate axon survival factors and promote SARM1-dependent axon degeneration. Mol. Neurobiol. 2020;57:1146&#x2013;1158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7035184</ArticleId><ArticleId IdType="pubmed">31696428</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy A.D., Devignot V., Fukata Y., Fukata M., Sobel A., Chauvin S. Subcellular Golgi localization of stathmin family proteins is promoted by a specific set of DHHC palmitoyl transferases. Mol. Biol. Cell. 2011;22:1930&#x2013;1942.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3103408</ArticleId><ArticleId IdType="pubmed">21471001</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutjens R., Igarashi M., Pellier V., Blasey H., Di Paolo G., Ruchti E., et al. Localization and targeting of SCG10 to the trans-Golgi apparatus and growth cone vesicles. Eur. J. Neurosci. 2000;12:2224&#x2013;2234.</Citation><ArticleIdList><ArticleId IdType="pubmed">10947801</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Paolo G., Lutjens R., Pellier V., Stimpson S.A., Beuchat M.-H., Catsicas S., et al. Targeting of SCG10 to the area of the Golgi complex is mediated by its NH2-terminal region. J.&#xa0;Biol. Chem. 1997;272:5175&#x2013;5182.</Citation><ArticleIdList><ArticleId IdType="pubmed">9030585</ArticleId></ArticleIdList></Reference><Reference><Citation>Riederer B.M., Pellier V., Antonsson B., Di Paolo G., Stimpson S.A., L&#xfc;tjens R., et al. Regulation of microtubule dynamics by the neuronal growth-associated protein SCG10. Proc. Natl. Acad. Sci. U. S. A. 1997;94:741&#x2013;745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC19584</ArticleId><ArticleId IdType="pubmed">9012855</ArticleId></ArticleIdList></Reference><Reference><Citation>Maekawa S., Morii H., Kumanogoh H., Sano M., Naruse Y., Sokawa Y., et al. Localization of neuronal growth-associated, microtubule-destabilizing factor SCG10 in brain-derived raft membrane microdomains. J.&#xa0;Biochem. 2001;129:691&#x2013;697.</Citation><ArticleIdList><ArticleId IdType="pubmed">11328590</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Shan C., Cao W., Zhang C., Teng J., Chen J. SCG10 promotes non-amyloidogenic processing of amyloid precursor protein by facilitating its trafficking to the cell surface. Hum. Mol. Genet. 2013;22:4888&#x2013;4900.</Citation><ArticleIdList><ArticleId IdType="pubmed">23863461</ArticleId></ArticleIdList></Reference><Reference><Citation>Summers D.W., Milbrandt J., DiAntonio A. Palmitoylation enables MAPK-dependent proteostasis of axon survival factors. Proc. Natl. Acad. Sci. U. S. A. 2018;115:E8746&#x2013;E8754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6140512</ArticleId><ArticleId IdType="pubmed">30150401</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozon S., Maucuer A., Sobel A. The stathmin family. Molecular and biological characterization of novel mammalian proteins expressed in the nervous system. Eur. J. Biochem. 1997;248:794&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pubmed">9342231</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng D.C., Zhao T.T., Yeap Y.Y., Ngoei K.R., Bogoyevitch M.A. c-Jun N-terminal kinase phosphorylation of stathmin confers protection against cellular stress. J.&#xa0;Biol. Chem. 2010;285:29001&#x2013;29013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2937927</ArticleId><ArticleId IdType="pubmed">20630875</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip Y.Y., Yeap Y.Y., Bogoyevitch M.A., Ng D.C. Differences in c-Jun N-terminal kinase recognition and phosphorylation of closely related stathmin-family members. Biochem. Biophys. Res. Commun. 2014;446:248&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pubmed">24589734</ArticleId></ArticleIdList></Reference><Reference><Citation>Devaux S., Poulain F.E., Devignot V., Lachkar S., Irinopoulou T., Sobel A. Specific serine-proline phosphorylation and glycogen synthase kinase 3&#x3b2;-directed subcellular targeting of stathmin 3/Sclip in neurons. J.&#xa0;Biol. Chem. 2012;287:22341&#x2013;22353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3381194</ArticleId><ArticleId IdType="pubmed">22577147</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauvin S., Poulain F.E., Ozon S., Sobel A. Palmitoylation of stathmin family proteins domain a controls Golgi versus mitochondrial subcellular targeting. Biol. Cell. 2008;100:577&#x2013;591.</Citation><ArticleIdList><ArticleId IdType="pubmed">18422486</ArticleId></ArticleIdList></Reference><Reference><Citation>Charbaut E., Chauvin S., Enslen H., Zamaroczy S., Sobel A. Two separate motifs cooperate to target stathmin-related proteins to the Golgi complex. J.&#xa0;Cell Sci. 2005;118:2313&#x2013;2323.</Citation><ArticleIdList><ArticleId IdType="pubmed">15870110</ArticleId></ArticleIdList></Reference><Reference><Citation>Liedtke W., Leman E.E., Fyffe R.E., Raine C.S., Schubart U.K. Stathmin-deficient mice develop an age-dependent axonopathy of the central and peripheral nervous systems. Am. J. Pathol. 2002;160:469&#x2013;480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1850667</ArticleId><ArticleId IdType="pubmed">11839567</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahapatra N.R., Taupenot L., Courel M., Mahata S.K., O&#x2019;Connor D.T. The trans -Golgi proteins SCLIP and SCG10 Interact with chromogranin a to regulate neuroendocrine secretion. Biochemistry. 2008;47:7167&#x2013;7178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2576284</ArticleId><ArticleId IdType="pubmed">18549247</ArticleId></ArticleIdList></Reference><Reference><Citation>Holland S.M., Collura K.M., Ketschek A., Noma K., Ferguson T.A., Jin Y., et al. Palmitoylation controls DLK localization, interactions and activity to ensure effective axonal injury signaling. Proc. Natl. Acad. Sci. U. S. A. 2016;113:763&#x2013;768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4725513</ArticleId><ArticleId IdType="pubmed">26719418</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu J., Holland S.M., Ketschek A., Collura K.M., Hesketh N.L., Hayashi T., et al. Palmitoylation couples the kinases DLK and JNK3 to facilitate prodegenerative axon-to-soma signaling. Sci. Signal. 2022;15</Citation><ArticleIdList><ArticleId IdType="pubmed">35349303</ArticleId></ArticleIdList></Reference><Reference><Citation>Valakh V., Frey E., Babetto E., Walker L.J., DiAntonio A. Cytoskeletal disruption activates the DLK/JNK pathway, which promotes axonal regeneration and mimics a preconditioning injury. Neurobiol. Dis. 2015;77:13&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4402261</ArticleId><ArticleId IdType="pubmed">25726747</ArticleId></ArticleIdList></Reference><Reference><Citation>Valakh V., Walker L.J., Skeath J.B., DiAntonio A. Loss of the spectraplakin short stop activates the DLK injury response pathway in Drosophila. J.&#xa0;Neurosci. 2013;33:17863&#x2013;17873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3818558</ArticleId><ArticleId IdType="pubmed">24198375</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Zhang Y.V., Asghari Adib E., Stanchev D.T., Xiong X., Klinedinst S., et al. Restraint of presynaptic protein levels by Wnd/DLK signaling mediates synaptic defects associated with the kinesin-3 motor Unc-104. Elife. 2017;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5605197</ArticleId><ArticleId IdType="pubmed">28925357</ArticleId></ArticleIdList></Reference><Reference><Citation>Vohra B.P., Sasaki Y., Miller B.R., Chang J., DiAntonio A., Milbrandt J. Amyloid precursor protein cleavage-dependent and -independent axonal degeneration programs share a common nicotinamide mononucleotide adenylyltransferase 1-sensitive pathway. J.&#xa0;Neurosci. 2010;30:13729&#x2013;13738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3104322</ArticleId><ArticleId IdType="pubmed">20943913</ArticleId></ArticleIdList></Reference><Reference><Citation>Araki T., Sasaki Y., Milbrandt J. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science. 2004;305:1010&#x2013;1013.</Citation><ArticleIdList><ArticleId IdType="pubmed">15310905</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerdts J., Sasaki Y., Vohra B., Marasa J., Milbrandt J. Image-based screening identifies novel roles for IkappaB kinase and glycogen synthase kinase 3 in axonal degeneration. J.&#xa0;Biol. Chem. 2011;286:28011&#x2013;28018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3151046</ArticleId><ArticleId IdType="pubmed">21685387</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>